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Abstract
Objective To evaluate the correlation between chronological
and biological age by comparing the normograms of AFC,
AMH, and FSH.
Design Retrospective study
Setting Data were taken from patients who visited the
Infertility Clinic at Dr. Cipto Mangunkusumo General
Hospital Jakarta, Indonesia, between January 2008 and
December 2010.
Patient(s) Infertile women who visited the Infertility Clinic.
Intervention(s) None.
Main Outcome Measure(s) Normogram of AFC (n =366),
AMH (n =1616) and FSH (n =415).
Result(s) The correlations among AFC, AMH, FSH, and age
are statistically significant. Normograms of AFC and AMH
with 3rd, 10th, 25th, 50th, 75th, 90th, and 97th percentiles
showed a decrease in age where FSH increased. A cut-off value
of AFC, AMH, and FSH for poor responders was plotted at the
50th percentile of each normogram. Serum AMH and AFC
started to decline in women between 34 and 35 years old. We
found a relatively lower slope increase of FSH in older patients
compared to that of AFC and AMH. FSH was observed to be a
later predictor of biological age than AMH and AFC.
Conclusion(s) AMH predicted biological age earlier than
FSH or AFC. Normograms can provide a reference guide
for physicians to counsel infertile women. However, future
validation with longitudinal data is still needed.
Keywords Normogram . Anti-Mullerian hormone . Antral
follicle count . FSH
Introduction
As women age, their ability to produce oocytes of good
quality and quantity is going to decrease. This decreased
ability has been related to chronological or biological age,
which represents the ovarian reserve and its response to ovar-
ian stimulation [1]. In the last three decades, the mean age of
women delivering their first child has increased by up to
5 years [2] as a result of delayed marriage, delayed contracep-
tion, and an increased availability of assisted reproductive
technology (ART) [3]. Previous studies have shown that at
approximately 30 years, female fertility is reduced and that it
decreases more slowly between the ages of 30 and 35 years,
finally followed by rapid decrease [4]. The combination of
delaying pregnancy and the age-related decrease in fertility
has caused an increase in the proportion of women over
35 years old who undergo ART procedures [5].
Unfortunately, advancing age negatively influences the out-
come of ART; thus, optimization of and counseling regarding
the procedure’s outcome chances are highly important [6].
Chronological age is the age determined by passage of time
since birth; however, biological age is determined by physiolo-
gy rather than chronology. Although the chronological age is a
very important predictive factor for fertility and ovarian re-
sponse, it was found that reproductive aging varied among
individuals [1]. Chronological and biological aging may differ
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significantly, since both genetics and the environment contribute
to biological age [1]. Reproductive functions are more
influenced by biological than chronological age; the ovarian
reserve seems to be a good marker for the biological age of the
ovary.
Many studies evaluating ovarian aging attempt to assess the
ovarian reserve and its response to stimulation [7, 8]. Biological
markers such as the serum level of Anti-Mullerian Hormone
(AMH), inhibin B, estradiol, and FSH have been assessed, and
many studies have compared their effectiveness with clinical
implications to predict the ovarian reserve [9–12]. Antral
Follicle Count (AFC), measured by transvaginal ultrasound,
and AMH were found to have good predictive values in deter-
mining the ovarian reserve [7, 8, 13] and are superior to FSH in
earlier predicting the ovarian reserve.
Knowing the ovarian biological age of a woman and the
subsequent diminishing pattern is highly important in the field
of ART, representing the basic principle of choosing the proce-
dure suitable for each woman. Several studies have aimed to
describe the relationship between the chronological age and
ovarian biological age by a value predicting the ovarian reserve,
such as AFC [14] and AMH serum levels [15, 16]. The objec-
tive of this study is to evaluate the correlation between chrono-
logical age and ovarian biological age using a normogram of
AFC, AMH, and FSH.
Materials and methods
This is a retrospective study in which all data on AFC, FSH
and AMH were taken from the medical records of patients
who underwent IVF at Yasmin IVF Clinic at Dr. Cipto
Mangunkusumo General Hospital from January 2008 to
December 2010. The study population included Indonesian
Fig. 1 Linear regression correlation curves between AFC, AMH, and FSH and age
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women aged 18–50 years old who went through AMH and
FSH level tests, as well as women aged 18–50 years old who
underwent AFC examination as part of in vitro fertilization
procedures. Patients with a history of chemotherapy or radia-
tion were excluded. The same physician using an Aloka type
SSD-3500 on day 2 or 3 following menstruation performed a
transvaginal ultrasound. Serum FSH was measured using an
Immulite 1000 FSH (Siemens Medical Solutions, UK) on day
2 or 3 following menstruation. AMH levels were measured on
any other day during the menstrual cycle using an AMH Gen
II ELISA (Beckman/Coulter, USA).
All data were analyzed using SPSS 11 (SPSS Inc, Chicago,
IL) to determine the correlations among AFC, AMH, FSH,
and the patients’ ages with the Pearson correlation test and
linear regression analysis. A graph based on the percentile age
for each variable using LMS (The Institute of Child Health,
London, UK) was then developed. This method has common-
ly been used to produce percentile data in studies with large
populations and have gone through quality control [17]. Seven
empirical percentiles, including the 3rd, 10th, 25th, 50th, 75th,
90th, 97th percentiles, and normogram tables were then
developed.
Result and discussion
The subject number, age and data distribution of each variable
are shown in Fig. 1. Before the correlations between AFC,
AMH and FSH with age are tested, the normality of data
distribution is confirmed through Kolmogorov-Smirnov nor-
mality test, shown in Table 1. The correlations between AFC,
AMH, and FSH and age are statistically significant.
The antral follicle count and serum AMH decreased with
increasing age, whereas serum FSH actually increased with
advancing age. These results are consistent with previous
studies that showed AMH to have a similar sloping pattern
compared to advancing age [18]. On the other hand [13], FSH
had a negative correlation with age, compared to AFC and
AMH. The relatively lower slopes of increasing FSH in older
age have made FSH a late predictor of ovarian reserves.
Figure 2a shows a linear biphasic correlation between AFC
and age. The graph shows a relatively flat AFC loss at younger
ages, followed by a faster decrease in the number of follicles
after a certain age, which is called a “switching age”. It was
found that the decreasing pattern is quite similar for all per-
centiles, with 33 years old considered the switching age.
These findings are slightly different from the results of a study
with 1.866 samples by Almog et al. [14]. Their study found a
similar linear biphasic correlation; however, each percentile
had a different switching age, as in the lower percentile groups
the acceleration of AFC loss started at a younger age. Faddy
et al. [19] found a bi-exponential decrease of AFC at the 4th
decade of a woman’s life, representing an accelerated follicle
loss. These differences show that the mechanism of follicle
loss has not yet been well described. Many genetic and envi-
ronmental factors that influence follicle loss have also not yet
been identified. Wiweko et al. [20] studied the female
Indonesian population and found that 8 antral follicles is the
cut-off value for determining a poor responder.
Figure 2b illustrates the linear correlation of serum AMH
levels with age. It was generally found that serumAMH levels
decreased in a linear fashion, although there was a slight
different result in the 90th and 97th percentiles, where an
increase in serum AMH among 22- to 24-year-old women
was noted on both percentiles [9, 13, 15, 16]. This difference
might be caused by a few of the subjects of this particular age
being PCOS patients and thus might not represent the general
population. Our previous study showed that serum AMH has
a cut-off value of 1.4 ng/ml for predicting poor responders. A
Table 1 Normality tests for AFC, AMH and FSH with age
Age AFC
N 399 399
Normal parametera,,b Mean 35.18 7.44
Std. Deviation 4.765 3.447
Extreme variance Absolute .064 .084
Positive .043 .084
Negative −.064 −.071
Kolmogorov-Smirnov Z 1.271 1.681
Asymp. Sig. (2-tailed) .079 .007
a. Data distribution test result: Normal.
b. Calculated from data
Age AMH
N 1616 1616
Normal parametera,,b Mean 36.06 2.6996
Std. Deviation 5.274 3.39615
Extreme variance Absolute .066 .220
Positive .052 .182
Negative −.066 −.220
Kolmogorov-Smirnov Z 2.657 8.850
Asymp. Sig. (2-tailed) .000 .000
a. Data distribution test result: Normal.
b. Calculated from data
Age FSH
N 415 415
Normal parametera,,b Mean 35.2675 7.7573
Std. Deviation 4.77951 4.40821
Extreme variance Absolute .073 .168
Positive .041 .168
Negative −.073 −.112
Kolmogorov-Smirnov Z 1.478 3.431
Asymp. Sig. (2-tailed) .025 .000
a. Data distribution test result: Normal.
b. Calculated from data
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study byNelson et al. (2011) with 9.601 infertile women showed
that serum AMH will decrease with age [16] and found that
serumAMH in all percentiles were lower compared to our study.
This difference might be caused by several factors, including
different populations with different genetic and environmental
backgrounds, which could lead to a different ovarian biological
age compared to chronological age [1]. Seiffer et al. (2011) also
studied serumAMH related to women’s ages with a total sample
of 17.120 women who came to an infertility center in the United
States [15]. The mean of age was similar to that in the current
study, although the median was lower than our value. Both of the
studies above did not correlate serum AMH, AFC and FSH as
markers of ovarian reserves.
The correlation between serum FSH and age (Fig. 2c)
showed that serum FSH levels increase with age. The linear
curve for each FSH percentile showed a minimal increase,
supporting the hypothesis that a decreased fertility evaluated
by FSH would appear later than the other two markers. Many
studies that compared serum FSH levels with other parame-
ters, such as AMH, inhibin B and antral follicle counts,
reported results similar to our results [7, 8, 12]. Our previous
study showed that the cut-off value for FSH to predict poor
responders was 7, 06 mIU/mL [20].
Based on all of the three graphs shown above, there were
biphasic curve changes of AFC, whereas serum AMH and FSH
changed in a linear pattern. It was predicted that a decrease in
female fertility occurs in a biphasic fashion, but now it is believed
that the decreasing fertility could follow a linear pattern [1]. In
another study, Rosen et al. found the onlymarkers that follow the
pattern of oocyte loss observed histologically were AFC and
AMH [21]. However there are no study mentioned about
switching age of declining fertility which is actually very impor-
tant for counseling of patients before treatment.
For this kind of purposes we define biological aging as the
ovarian follicular capacity in producing oocytes. Knowing
that poor ovarian response is an early sign of ovarian aging,
we used cut-off values for AFC, AMH and FSH for poor
responder developed from our previous study to correlate with
our normogram [20]. We plotted each cut-off value of AFC,
Table 2 Cut-off value for AFC, AMH and FSH determined biological
age
Percentile AFC (yr) AMH (yr) FSH (yr)
3 NA NA NA
10 NA 19 22
25 NA 23 34
50 34 35 43
75 40 41 48
90 43 46 NA
97 46 NA NA




Fig. 2 Correlation between the 3rd, 10th, 25th, 50th, 75th, 90th,
and 97th percentiles of AFC (a), serum AMH (b) and serum FSH (c)
related to age
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AMH and FSHwithin the 50th percentile of the normogram in
order to determine the switching age of declining fertility. This
result is shown in Table 2.
Table 2 shows that for each percentile, AMH predicts
ovarian aging earlier than FSH. This result is consistent with
a study by Gleicher et al. that reported women with normal
AMH and FSH produced high number of oocytes, whereas
women with normal FSH but decreasing AMH produced a
significantly lower number of oocytes [22]. This also indicates
that AMH serum levels are more important predictors of
ovarian aging than FSH levels. This is similar with previous
studies by Barad et al. that shows that AMH levels are better
predictors of response to ovarian stimulation and clinical
pregnancy than baseline FSH levels [23].
The limitation of our study is that we did not calculate the
correlation of ovarian aging and the rate of successful IVF or IUI
treatment and live birth. Therefore, we don’t have any evidence
that having a high percentile of AFC or AMH is predictive of
higher likelihood to have a successful IVF or IUI treatment, nor
can the probability of having a natural conception be based on
the percentile. Based on these facts, clinicians cannot infer live
birth rates from the normograms as presented in this study.
In conclusion, the current study reveals that AFC and serum
AMHdecrease with age, whereas FSH levels increase. The AFC
curve changed in a biphasic fashion, while AMH and FSH
changed linearly. The change in serum AMH occurs earlier than
in AFC or serum FSH; therefore, serum AMH is an earlier
predictor for biological age. The normogram produced in this
study could be used for counseling women to identify their
biological age. The clinical significance of this study is that the
clinicians could estimate the possibility of better response to
ovarian stimulation among different patients.
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